Cargando…

Inverse relation between FASN expression in human adipose tissue and the insulin resistance level

BACKGROUND: Adipose tissue is a key regulator of energy balance playing an active role in lipid storage and may be a dynamic buffer to control fatty acid flux. Just like PPARγ, fatty acid synthesis enzymes such as FASN have been implicated in almost all aspects of human metabolic alterations such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayas, María D, Ortega, Francisco J, Macías-González, Manuel, Bernal, Rosa, Gómez-Huelgas, Ricardo, Fernández-Real, José M, Tinahones, Francisco J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820025/
https://www.ncbi.nlm.nih.gov/pubmed/20148112
http://dx.doi.org/10.1186/1743-7075-7-3
Descripción
Sumario:BACKGROUND: Adipose tissue is a key regulator of energy balance playing an active role in lipid storage and may be a dynamic buffer to control fatty acid flux. Just like PPARγ, fatty acid synthesis enzymes such as FASN have been implicated in almost all aspects of human metabolic alterations such as obesity, insulin resistance or dyslipemia. The aim of this work is to investigate how FASN and PPARγ expression in human adipose tissue is related to carbohydrate metabolism dysfunction and obesity. METHODS: The study included eighty-seven patients which were classified according to their BMI and to their glycaemia levels in order to study FASN and PPARγ gene expression levels, anthropometric and biochemical variables. RESULTS: The main result of this work is the close relation between FASN expression level and the factors that lead to hyperglycemic state (increased values of glucose levels, HOMA-IR, HbA1c, BMI and triglycerides). The correlation of the enzyme with these parameters is inversely proportional. On the other hand, PPARγ is not related to carbohydrate metabolism. CONCLUSIONS: We can demonstrate that FASN expression is a good candidate to study the pathophysiology of type II diabetes and obesity in humans.